Skip to content
2000
  • ISSN: 1568-010X
  • E-ISSN: 1568-010X

Abstract

Endothelial cells are involved in leukocyte extravasation underlying inflammation. A number of adhesion molecules play a role in leukocyte-endothelial interactions. New vessel formation, termed angiogenesis, is also crucial for leukocyte extravasation. The outcome of neovascularization is highly dependent on the balance or imbalance between angiogenic mediators and inhibitors. There have been several attempts to therapeutically interfere with the cellular and molecular mechanisms, such as leukocyte-endothelial cell adhesion and angiogenesis. Most studies have been performed using animal models of various types of inflammation, such as arthritis. In addition, a very limited number of human clinical trials gave promising results. In this review, authors summarize the most relevant information on adhesion molecules, as well as angiogenic and angiostatic agents. In addition, further perspectives of anti-adhesive and anti-angiogenic therapy are also discussed. Specific targeting of pathological endothelial function including adhesion and angiogenesis, may be useful for the future management of various inflammatory diseases.

Loading

Article metrics loading...

/content/journals/cdtia/10.2174/1568010054022187
2005-06-01
2025-06-26
Loading full text...

Full text loading...

/content/journals/cdtia/10.2174/1568010054022187
Loading

  • Article Type:
    Review Article
Keyword(s): angiogenesis; endothelial cells; inflammation; rheumatoid arthritis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test